ArticleJournal of comparative effectiveness research2026

The value of time savings in breast cancer therapy for patients and healthcare providers: the subcutaneous injection of pertuzumab and trastuzumab fixed-dose combination at a tertiary care center in the UAE.

Khaled H A Al QawasmehPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.